Turbocharged Cells Show Promise for Autoimmune Diseases
Kilder
- Nature: Turbocharged ‘killer’ cells show promise for autoimmune disease - Nature
- Statnews: Cogent Biosciences drug improves symptoms of chronic immune disorder, study results show - STAT
- Fiercebiotech: Cell therapy biotech shares first clinical data for in vivo CAR-T that attracted $1B AstraZeneca acquisition - Fierce Biotech
- Fiercebiotech: Roche’s Chugai inks $250M Gero deal to access age-related disease targets - Fierce Biotech
- Fiercebiotech: Cogent’s phase 3 hits primary endpoint, building case for filing to challenge Blueprint’s Ayvakit - Fierce Biotech
- Nature: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR - Nature
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.